Our global health research improves health and wellbeing of people in low- and middle-income countries. We conduct multi-disciplinary research with experts throughout the world, spanning basic clinical science, epidemiology, applied health research, health system and health policy research, and health economics.

Our Recent Research Projects

Lead by Professor Dion Morton

The GlobalSurg Collaborative was established to represent practicing surgeons from all around the world. We conduct collaborative international research into surgical outcomes by fostering local, national and international research networks. The GlobalSurg network now includes over 5000 clinicians in more than 100 countries. The ethos is inclusive and collaborative: our international cohort studies are open to all collaborators, including medical students, clinical officers, doctors, nurses and researchers. Any hospital, anywhere in the world, treating patients that meet study inclusion criteria are eligible to take part.

  • NIHR Global Health Group EQUI-Injury

Lead by Professor Justine Davies at the University of Birmingham, UK and Kat Chu, Stellenbosch University, South Africa

The aim of this Global Health grant is to help reduce the likelihood of people in developing countries dying unnecessarily from injuries. With partners in Ghana, South Africa, Rwanda, and Pakistan, we will address both delays in access to care and quality of care provided to the injured, to reduce death or disability. Our partner institutions include University of Birmingham, University of Aberdeen; University of York; University of Rwanda; University of Global Health Equity, Rwanda; Ministry of Health, Rwanda; The Aga Khan University; University for Development Studies, Ghana; Stellenbosch University, and is co-led by Stellenbosch, South Africa

Led by Professor Adam Cunningham

BactiVac, the Bacterial Vaccines Network, brings together members based in academic, industry and policy sectors to accelerate the development of vaccines against bacterial infections relevant to low and middle-income countries (LMICs). The BactiVac Network delivers this through catalyst project and training awards to encourage cross-collaboration between academic and industrial partners in developed and developing nations. The BactiVac Network brings together academic, industrial and other partners involved in vaccine research against human and animal bacterial infections from the UK and LMICs.

Led by Dr Semira Manaseki-Holland

Diarrhoea causes 1 in 9 under-five deaths worldwide. The MaaCiwara Study, set in Mali, exams interventions aimed at reducing the burden of diarrhoea among children eating complementary food, particularly behavioural interventions that influence food hygiene, food content and safe play. It is comprised of a Cluster RCT, testing a low-cost, scalable and adaptable community intervention to reduce diarrhoea and improve the growth of young children in urban and rural Mali. We will assess the effects in both settings, to inform replication and scaling of the intervention, because the dynamics of community life vary in each.

Lead by Professor Richard Lilford

The overall aim of the research is to improve self-care in the community for leprosy patients who are at risk of recurrent ulceration and further disfigurement and disability and to better understand the needs of Buruli ulcer patients and the barriers to meeting those needs, in Nigeria, Nepal and India.

Our Global Partners

Map global health1

We work with collaborators in 30 countries in 6 continents. 




North America


South America